FI906162A7 - Menetelmä valmistaa 3-(N-metyyli-N-alkyyli)-amino-2-metoksimetyleenipropan-1-olijohdoksia - Google Patents

Menetelmä valmistaa 3-(N-metyyli-N-alkyyli)-amino-2-metoksimetyleenipropan-1-olijohdoksia Download PDF

Info

Publication number
FI906162A7
FI906162A7 FI906162A FI906162A FI906162A7 FI 906162 A7 FI906162 A7 FI 906162A7 FI 906162 A FI906162 A FI 906162A FI 906162 A FI906162 A FI 906162A FI 906162 A7 FI906162 A7 FI 906162A7
Authority
FI
Finland
Prior art keywords
methoxymethylenepropan
derivatives
amino
alkyl
methyl
Prior art date
Application number
FI906162A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI906162L (fi
FI906162A0 (fi
Inventor
Pierre Braquet
Colette Broquet
Bénédicte Vandamme
Paola Principe-Nicolas
Original Assignee
Soc De Conseils De Recherches Et Dapplications Scientifiques S C R A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc De Conseils De Recherches Et Dapplications Scientifiques S C R A S filed Critical Soc De Conseils De Recherches Et Dapplications Scientifiques S C R A S
Publication of FI906162A0 publication Critical patent/FI906162A0/fi
Publication of FI906162L publication Critical patent/FI906162L/fi
Publication of FI906162A7 publication Critical patent/FI906162A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
FI906162A 1989-12-19 1990-12-14 Menetelmä valmistaa 3-(N-metyyli-N-alkyyli)-amino-2-metoksimetyleenipropan-1-olijohdoksia FI906162A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928580A GB8928580D0 (en) 1989-12-19 1989-12-19 3-(n-methyl-n-alkylamino)-methoxymethyl-propanol phosphocholine derivatives

Publications (3)

Publication Number Publication Date
FI906162A0 FI906162A0 (fi) 1990-12-14
FI906162L FI906162L (fi) 1991-06-20
FI906162A7 true FI906162A7 (fi) 1991-06-20

Family

ID=10668132

Family Applications (1)

Application Number Title Priority Date Filing Date
FI906162A FI906162A7 (fi) 1989-12-19 1990-12-14 Menetelmä valmistaa 3-(N-metyyli-N-alkyyli)-amino-2-metoksimetyleenipropan-1-olijohdoksia

Country Status (32)

Country Link
US (1) US5118674A (enExample)
JP (1) JPH04208256A (enExample)
KR (1) KR910011759A (enExample)
AR (1) AR246742A1 (enExample)
AT (1) AT400333B (enExample)
AU (1) AU630056B2 (enExample)
BE (1) BE1004089A3 (enExample)
CA (1) CA2032224C (enExample)
CH (1) CH681624A5 (enExample)
DE (1) DE4040685A1 (enExample)
DK (1) DK171298B1 (enExample)
DZ (1) DZ1471A1 (enExample)
ES (1) ES2023607A6 (enExample)
FI (1) FI906162A7 (enExample)
FR (2) FR2656797B1 (enExample)
GB (2) GB8928580D0 (enExample)
GR (1) GR1000893B (enExample)
HK (1) HK118093A (enExample)
IE (1) IE65888B1 (enExample)
IN (1) IN173969B (enExample)
IT (1) IT1243412B (enExample)
LU (1) LU87853A1 (enExample)
MA (1) MA22013A1 (enExample)
MY (1) MY104781A (enExample)
NL (1) NL9002582A (enExample)
NO (1) NO177146C (enExample)
NZ (1) NZ236213A (enExample)
OA (1) OA09475A (enExample)
PT (1) PT96265B (enExample)
SE (1) SE469383B (enExample)
TN (1) TNSN90152A1 (enExample)
ZA (1) ZA909663B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1132586C (zh) 1993-09-09 2003-12-31 罗拉斯医疗公司 来自胆汁的免疫调节组合物、其制备方法及其用途
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
BR9607967A (pt) 1995-03-16 1998-01-13 Imutec Pharma Inc Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
DE19711758C2 (de) * 1997-03-21 2003-06-18 Degussa Verfahren zur Herstellung von 1,3-Dioxanverbindungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732263A1 (de) * 1977-07-16 1979-02-01 Schuler Gmbh L Vorrichtung zum herstellen einer sicke am umfang eines hohlzylinders
DE2820893C2 (de) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use
WO1989007099A1 (en) * 1988-02-05 1989-08-10 Schering Corporation 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
JP2534893B2 (ja) * 1988-06-24 1996-09-18 日本ケミファ株式会社 新規なグリセリン誘導体およびその誘導体を含有する血小板凝集抑制剤
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
GR1000688B (el) * 1989-12-22 1992-10-08 Sod Conseils Rech Applic Μεθοδος παρασκευης παραγωγων γλυκερινης.

Also Published As

Publication number Publication date
CA2032224A1 (en) 1991-06-20
IT1243412B (it) 1994-06-10
FI906162L (fi) 1991-06-20
GB8928580D0 (en) 1990-02-21
CH681624A5 (enExample) 1993-04-30
FR2656797A1 (fr) 1991-07-12
FR2656307B1 (fr) 1992-09-18
DK171298B1 (da) 1996-08-26
PT96265B (pt) 1998-06-30
NO177146B (no) 1995-04-18
FI906162A0 (fi) 1990-12-14
AT400333B (de) 1995-12-27
SE9004039L (sv) 1991-06-20
FR2656797B1 (fr) 1992-09-18
GR1000893B (el) 1993-03-16
CA2032224C (en) 1996-12-10
US5118674A (en) 1992-06-02
NZ236213A (en) 1993-03-26
BE1004089A3 (fr) 1992-09-22
ATA259590A (de) 1995-04-15
ES2023607A6 (es) 1992-01-16
SE469383B (sv) 1993-06-28
DK299590D0 (da) 1990-12-18
PT96265A (pt) 1991-09-30
NO177146C (no) 1995-07-26
HK118093A (en) 1993-11-12
AR246742A1 (es) 1994-09-30
ZA909663B (en) 1991-09-25
GB9027421D0 (en) 1991-02-06
KR910011759A (ko) 1991-08-07
IT9022438A0 (it) 1990-12-19
IE65888B1 (en) 1995-11-29
LU87853A1 (fr) 1991-05-07
FR2656307A1 (fr) 1991-06-28
NL9002582A (nl) 1991-07-16
GB2239239A (en) 1991-06-26
TNSN90152A1 (fr) 1991-03-05
DE4040685A1 (de) 1991-06-20
GB2239239B (en) 1993-06-02
AU630056B2 (en) 1992-10-15
DK299590A (da) 1991-06-20
MA22013A1 (fr) 1991-07-01
NO905373D0 (no) 1990-12-12
OA09475A (fr) 1992-11-15
IN173969B (enExample) 1994-08-13
SE9004039D0 (sv) 1990-12-18
MY104781A (en) 1994-05-31
JPH04208256A (ja) 1992-07-29
GR900100812A (en) 1992-05-12
DZ1471A1 (fr) 2004-09-13
NO905373L (no) 1991-06-20
IE904567A1 (en) 1991-06-19
AU6814290A (en) 1991-06-27
IT9022438A1 (it) 1992-06-19

Similar Documents

Publication Publication Date Title
FI905941A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI894217L (fi) 1-adamantaanijohdannaisten valmistusmenetelmä
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI893361L (fi) Menetelmä ACAT-inhiboivien kinoliinijohdannaisten valmistamiseksi
BG49939A3 (bg) Метод за получаване на 2-анилино-пиримидинови производни
FI891711L (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
FI891700L (fi) Menetelmä beta-laktaamijohdannaisten valmistamiseksi
FI905536A7 (fi) Menetelmä N-glykosidijohdannaisten valmistamiseksi
FI895676L (fi) Menetelmä massan valmistamiseksi
FI95036B (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI923498A7 (fi) Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi
FI904393A7 (fi) Parannettu menetelmä amidoksiimijohdannaisten valmistamiseksi
FI893003L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI891677L (fi) Menetelmä 4-demetoksidaunomysinonin valmistamiseksi
FI906203A7 (fi) Glyserolijohdosten valmistusmenetelmä
FI891362A7 (fi) Menetelmä uusien alkanofenonien valmistamiseksi
FI895800A7 (fi) Menetelmä uusien a-syano-b-oksopropioniamidien valmistamiseksi
NO901071D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
FI893478L (fi) Menetelmä uusien kysteiinijohdannaisten valmistamiseksi
FI890293A7 (fi) Menetelmä tioformamidijohdannaisten valmistamiseksi
FI893567A7 (fi) Menetelmä glykosfingolipidijohdannaisten valmistamiseksi
FI890624A7 (fi) Menetelmä tiofeenieetterien valmistamiseksi
FI901098A7 (fi) N-allyylimetatrifluorometyylianiliinin valmistusmenetelmä
FI885839A7 (fi) Menetelmä tioformamaidijohdannaisten valmistamiseksi
FI903754A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten lysogangliosidijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: SOCIETE DE CONSEILS DE RECHERCHES ET D APPLICATION